Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 11/20 | 0.55 |
| ▸ | ESR1 | P03372 | 10/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.51 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.49 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13851833 | 0.88 | HSD17B1 (0.47) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL24431730 | 0.85 | FTO (0.47) | ESR2ESR1 | |
| SCHEMBL15908090 | 0.85 | TSHR (0.58) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL632019 | 0.84 | ESR2 (0.72) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL494006 | 0.83 | ALOX5 (0.60) | ESR2ESR1ALOX5 | |
| SCHEMBL29740228 | 0.83 | ALOX5 (0.60) | ESR2ESR1ALOX5 | |
| SCHEMBL29649729 | 0.82 | ALOX5 (0.64) | ESR2ESR1ALOX5 | |
| SCHEMBL1243192 | 0.82 | ALOX5 (0.64) | ESR2ESR1ALOX5 | |
| SCHEMBL29649804 | 0.82 | ALOX5 (0.64) | ESR2ESR1ALOX5 | |
| SCHEMBL6563798 | 0.82 | ALOX5 (0.64) | ESR2ESR1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050169859-A1 | Naphthyltriazines as stabilizers for organic material | TOAN VIEN V (CH) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050169859-A1 | Naphthyltriazines as stabilizers for organic material | POT1, H1-2, TYR | ESR2 626/4885ESR1 1006/4885CYP1A2 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.